Zusammenfassung
Unter Tumormarkern versteht man Substanzen, die bei Patienten mit malignen Tumoren im Blut oder in anderen Körperflüssigkeiten in erhöhten Konzentrationen nachweisbar sind. Prinzipiell kann die Synthese der Tumormarker im Tumorgewebe selbst erfolgen, oder Tumorzellen induzieren die Synthese in Nicht-Tumorzellen. Nur die vom Tumorgewebe selbst gebildeten Marker besitzen eine ausreichende Spezifität für die Tumordiagnostik.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bagshawe KD (1992) Choriocarcinoma. A model for tumour markers. Acta Oncol 31:99–106
Barry MJ (2001) Prostate-specific antigen testing for early diagnosis of prostate cancer. N Engl J M 344:1373–1377
Bast RC Jr, Ravdin P, Hayes DF et al (2001) 2000 Update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Invest 19:1865–1878
Berger P, Sturgeon C, Bidart JM et al (2002) The ISOBM TD-7Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumour Biol 23:1–38
Bosl GJ, Head MO (1994) Serum tumor marker half-life during chemotherapy in patients with gene cell tumors. Int J Biol Markers 9:25–28
Catalona WJ, Partin AW, Slawin KM et al (1998) Use of the percentage of free prostatespecific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279:1542–1547
Duffy MJ (2001) Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 47:624–630
Ebert W, Muley T, Drings P (1996) Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Anticancer Res 16:2161–2168
Filella X, Fuster J, Molina R et al (1994) TAG-72, CA 19-9 and CEA as tumor markers in gastric cancer. Acta Oncol 33:747–751
Mann K (2002) Diagnostik und Therapie differenzierter Schilddrüsenkarzinome. Internist 43:174–185
Mann K, Saller B, Hoermann R (1993) Clinical use of hCG and hCG beta determinations. Scand J Clin Lab Invest Suppl 216:97–104
Molina R, Filella X, Torres MD et al (1990) SCC antigen measured in malignant and non-malignant diseases. Clin Chem 36:251–254
NIH Consensus Development Panel (1995) NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA 273:491–497
Safi F, Kohler I, Rottinger E et al (1991) The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen. Cancer 68:574–582
Schlumberger M, Baudin E (1998) Serum thyroglobulin determination in the followup of patients with differentiated thyroid carcinoma. Eur J Endocrinol 138:249–252
Smith RA, Cokkinides V, von Eschenbach AC et al (2002) American Cancer Society Guidelines for the early detection of cancer. CA Cancer J Clin 52:8–22
Wagener C (1995) Malignes Wachstum. In: Lehrbuch der Klinischen Chemie und Pathobiochemie, ed. U. Greiling, AM Gressner, Schattauer, Stuttgart New York, pp 1192–1256
Wagener C, Hossfeld DK (1996) Analytische und diagnostische Validität von Tumormarkern. Onkologe 2:278–286
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Nollau, P., Mann, K., Wagener, C. (2006). Tumormarker. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31303-6_26
Download citation
DOI: https://doi.org/10.1007/3-540-31303-6_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-20657-6
Online ISBN: 978-3-540-31303-8
eBook Packages: Medicine (German Language)